Palo Alto Networks (PANW) has been back in focus after cybersecurity peers reported strong quarters and raised outlooks, lifting confidence in AI security spending and putting extra attention on Palo Alto’s upcoming earnings.
After a sharp rally that included a 12% single day gain when peers like CrowdStrike and Okta reported strong results, Palo Alto Networks’ 30 day share price return of 18.3% and 90 day share price return of 31.9% signal building momentum. The 1 year total shareholder return of 95% and 5 year total shareholder return of 376% reflect how investors have been rewarding its AI focused partnerships and platform expansion.
Scan how other cybersecurity and AI-focused stocks are reacting to this shift in sentiment by reviewing the hand picked 56 AI infrastructure stocks alongside Palo Alto Networks.
Palo Alto Networks looks like a strong business riding powerful AI security themes. After a near 100% 1 year return and a 12% surge tied to peer results, the real question is how much of that strength is already in the price.
Most Popular Narrative: 10.4% Overvalued
Palo Alto Networks closed at $371.59 compared with a narrative fair value of $336.70, so the widely followed view sees the stock pricing in a premium today.
Ongoing industry consolidation, as enterprises seek to simplify and maximize the effectiveness of their security stack, has strengthened the trend towards platformization, resulting in larger multi-platform deal sizes, improved cross-sell, higher net retention rates (120%), and near zero churn among platformized clients, all of which support future margin expansion and earnings growth.
Want to understand why this narrative still supports a rich valuation multiple even after a strong run in Palo Alto Networks? The core is a specific revenue growth glide path, expanding margins and an earnings profile that leans heavily on recurring AI and cloud security cash flows. Curious how those assumptions stack up against the current analyst price target range and discount rate inputs.
Result: Fair Value of $336.70 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this rich Palo Alto Networks narrative could be tested if integration challenges around acquisitions or rising R&D and compliance costs begin to pressure margins.
Find out about the key risks to this Palo Alto Networks narrative.
Next Steps
If this Palo Alto Networks story appears to balance optimism and concern, consider reviewing the full range of risks and potential upsides yourself. To round out your view, take a close look at the 1 key reward and 3 important warning signs.
Looking for more investment ideas beyond Palo Alto Networks?
If Palo Alto Networks has sharpened your interest in where capital might work hardest, do not stop here. Use the Simply Wall Street Screener to uncover fresh opportunities across different styles and risk levels.
- Target potential mispricing by reviewing companies that appear attractively valued using the 44 high quality undervalued stocks.
- Prioritise resilience by checking companies with robust financial footing through the list of solid balance sheet and fundamentals (51 results).
- Pursue growth ideas off the radar by scanning the 19 high quality undiscovered gems before everyone else does.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New:Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
MI
mitchell_lawler
The Foxhole
A landmark settlement is meant to punish Meta (META). If the 1998 tobacco deal is any guide, it might protect it.
Any moat with an opt-out clause for your competitors is just a fence around your own garden.
Worth looking at what previous legal action actually did to Meta rather than reaching for tobacco. The FTC’s record five billion dollar privacy fine in 2019 was met with the stock rising, because it came in below fears and removed an open question. GDPR was designed to constrain large platforms and increased their share of the European ad market, because compliance cost fell hardest on small intermediaries. The FTC’s antitrust case, the one that could genuinely have broken the company up, was decided in Meta’s favour last November. The only thing that ever meaningfully hurt the business was Apple changing a tracking default, and Meta out-spent that too, while the ad-tech firms that could not afford to rebuild disappeared. The pattern is not that Meta survives regulation. It is that regulation keeps costing its smaller competitors more.
Great earnings season, but are the earnings real?
At first glance, this was the strongest earnings season in years. But when you look at where the growth actually came from, the story splits into two very different pictures.
10
Aug 28, 2026
About NasdaqGS:PANW
Palo Alto Networks
Provides cybersecurity solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan.
Reasonable growth potential with adequate balance sheet.
Similar Companies
Market Insights
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Picking portfolio winners takes more than hot airAN
Andrew Legget
Advertisement
Weekly Picks
Lou_Baseneseon Oncolytics Biotech·11 days ago
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
Fair Value:US$3.575.5% undervalued
28followersusers have followed this narrative
·0commentsusers have commented on this narrative
·7likesusers have liked this narrative
TR
tripledubon Meta Platforms·25 days ago
The $135 Billion Bet That Should Make Every Shareholder Nervous
Taloson Voyager Technologies·20 days ago
The “Landlord of Orbit” – A Deep Value Play Ahead of the Starlab Era
Ivoedon Uber Technologies·14 days ago
Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides
RecentlyUpdated Narratives
dangon Resonance Health·about 11 hours ago
Resonance Health will triple revenue growth to 30.83% in five years
RockeTelleron Santacruz Silver Mining·about 16 hours ago
Santacruz Silver, 5.6M Oz Silver Producer Trading at Low Multiples, 100X Per-Share Upside in $200 Silver
Fair Value:CA$142.990.7% undervalued
96followersusers have followed this narrative
·14commentsusers have commented on this narrative
·0likesusers have liked this narrative
CO
composite32on Eaton·about 19 hours ago
“Grid-to-Chip: How Eaton Controls the Physical Bottlenecks of AI Data Centers”
Popular Narratives
oscargarciaon NVIDIA·3 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
CubanEroson Microsoft·about 2 months ago
A wonderful business at reasonable price.
Fair Value:US$419.9122.3% overvalued
213followersusers have followed this narrative
·0commentsusers have commented on this narrative
·9likesusers have liked this narrative
KI
KiwiInveston Amazon.com·4 months ago
